These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 10712599)

  • 1. Degradation of transcription factor IRF-1 by the ubiquitin-proteasome pathway. The C-terminal region governs the protein stability.
    Nakagawa K; Yokosawa H
    Eur J Biochem; 2000 Mar; 267(6):1680-6. PubMed ID: 10712599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiproliferative proteins of the BTG/Tob family are degraded by the ubiquitin-proteasome system.
    Sasajima H; Nakagawa K; Yokosawa H
    Eur J Biochem; 2002 Jul; 269(14):3596-604. PubMed ID: 12135500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation.
    Lin R; Heylbroeck C; Pitha PM; Hiscott J
    Mol Cell Biol; 1998 May; 18(5):2986-96. PubMed ID: 9566918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-Myc proteolysis by the ubiquitin-proteasome pathway: stabilization of c-Myc in Burkitt's lymphoma cells.
    Gregory MA; Hann SR
    Mol Cell Biol; 2000 Apr; 20(7):2423-35. PubMed ID: 10713166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct demonstration of rapid degradation of nuclear sterol regulatory element-binding proteins by the ubiquitin-proteasome pathway.
    Hirano Y; Yoshida M; Shimizu M; Sato R
    J Biol Chem; 2001 Sep; 276(39):36431-7. PubMed ID: 11477106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathway.
    Rousseau D; Cannella D; Boulaire J; Fitzgerald P; Fotedar A; Fotedar R
    Oncogene; 1999 May; 18(21):3290-302. PubMed ID: 10359535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Degradation of proto-oncoprotein c-Rel by the ubiquitin-proteasome pathway.
    Chen E; Hrdlickova R; Nehyba J; Longo DL; Bose HR; Li CC
    J Biol Chem; 1998 Dec; 273(52):35201-7. PubMed ID: 9857058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interplay between repressing and activating domains defines the transcriptional activity of IRF-1.
    Kirchhoff S; Oumard A; Nourbakhsh M; Levi BZ; Hauser H
    Eur J Biochem; 2000 Dec; 267(23):6753-61. PubMed ID: 11082185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Degradation of E2F by the ubiquitin-proteasome pathway: regulation by retinoblastoma family proteins and adenovirus transforming proteins.
    Hateboer G; Kerkhoven RM; Shvarts A; Bernards R; Beijersbergen RL
    Genes Dev; 1996 Dec; 10(23):2960-70. PubMed ID: 8956997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A glycine-rich region in NF-kappaB p105 functions as a processing signal for the generation of the p50 subunit.
    Lin L; Ghosh S
    Mol Cell Biol; 1996 May; 16(5):2248-54. PubMed ID: 8628291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Degradation of the Id2 developmental regulator: targeting via N-terminal ubiquitination.
    Fajerman I; Schwartz AL; Ciechanover A
    Biochem Biophys Res Commun; 2004 Feb; 314(2):505-12. PubMed ID: 14733935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory domain of protein stability of human P51/TAP63, a P53 homologue.
    Osada M; Inaba R; Shinohara H; Hagiwara M; Nakamura M; Ikawa Y
    Biochem Biophys Res Commun; 2001 May; 283(5):1135-41. PubMed ID: 11355891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein.
    Tanimoto K; Makino Y; Pereira T; Poellinger L
    EMBO J; 2000 Aug; 19(16):4298-309. PubMed ID: 10944113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Degradation of CFTR by the ubiquitin-proteasome pathway.
    Ward CL; Omura S; Kopito RR
    Cell; 1995 Oct; 83(1):121-7. PubMed ID: 7553863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ubiquitin/proteasome pathway regulates levels of retinoic acid receptor gamma and retinoid X receptor alpha in human keratinocytes.
    Boudjelal M; Wang Z; Voorhees JJ; Fisher GJ
    Cancer Res; 2000 Apr; 60(8):2247-52. PubMed ID: 10786691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway.
    Huang LE; Gu J; Schau M; Bunn HF
    Proc Natl Acad Sci U S A; 1998 Jul; 95(14):7987-92. PubMed ID: 9653127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of E2F through ubiquitin-proteasome-dependent degradation: stabilization by the pRB tumor suppressor protein.
    Campanero MR; Flemington EK
    Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2221-6. PubMed ID: 9122175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of interferon-gamma-activated STAT1 by the ubiquitin-proteasome pathway.
    Kim TK; Maniatis T
    Science; 1996 Sep; 273(5282):1717-9. PubMed ID: 8781235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-lived green fluorescent proteins for quantifying ubiquitin/proteasome-dependent proteolysis in living cells.
    Dantuma NP; Lindsten K; Glas R; Jellne M; Masucci MG
    Nat Biotechnol; 2000 May; 18(5):538-43. PubMed ID: 10802622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Degradation of transcription repressor ZBRK1 through the ubiquitin-proteasome pathway relieves repression of Gadd45a upon DNA damage.
    Yun J; Lee WH
    Mol Cell Biol; 2003 Oct; 23(20):7305-14. PubMed ID: 14517299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.